~~<i id='1084511433'><strike id='1084511433'><tt id='1084511433'><pre id='1084511433'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：explore 2025-09-27 17:36:24 Page View：83

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hospitals are dialing back on venture capital investing
Next article： Alkermes shareholders re

explore

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Complete sequence of Y chromosome published for first time

Akaryotype,orchromosomalprofileCDCTwoyearsago,whenaninternationalteamofscientistsannouncedithadfinal

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

Winners, losers from Medicare’s list of drugs subject to price talks

AdobeOnTuesdaymorning,theDepartmentofHealthandHumanServicesunveileditslong-awaitedlistofthe10medicin